Last reviewed · How we verify
Merz Aesthetics GmbH — Portfolio Competitive Intelligence Brief
1 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| NT 201 | NT 201 | marketed | Botulinum toxin type A | SNARE complex (acetylcholine release machinery) | Aesthetics/Dermatology |
Therapeutic area mix
- Aesthetics/Dermatology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- ATGC Co., Ltd. · 1 shared drug class
- Assistance Publique - Hôpitaux de Paris · 1 shared drug class
- Brigitte Schürch · 1 shared drug class
- Carruthers Dermatology Centre · 1 shared drug class
- Department of Medical Services Ministry of Public Health of Thailand · 1 shared drug class
- Galderma R&D · 1 shared drug class
- Huons Co., Ltd. · 1 shared drug class
- Innovaderm Research Inc. · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Merz Aesthetics GmbH:
- Merz Aesthetics GmbH pipeline updates — RSS
- Merz Aesthetics GmbH pipeline updates — Atom
- Merz Aesthetics GmbH pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Merz Aesthetics GmbH — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/merz-aesthetics-gmbh. Accessed 2026-05-16.